| Red River Behavioral Health, Llc | |
|
140 Windermere Blvd Ste C Alexandria LA 71303-3583 | |
| (318) 528-8679 | |
| (844) 907-2983 |
| Full Name | Red River Behavioral Health, Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 140 Windermere Blvd Ste C, Alexandria, Louisiana |
| Authorized Official Name and Position | Adam B Hess (CLINICAL PSYCHOLOGIST) |
| Authorized Official Contact | 3187943801 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Red River Behavioral Health, Llc 140 Windermere Blvd Ste C Alexandria LA 71303-3583 Ph: (318) 528-8679 | Red River Behavioral Health, Llc 140 Windermere Blvd Ste C Alexandria LA 71303-3583 Ph: (318) 528-8679 |
| NPI Number | 1134491855 |
|---|---|
| Provider Enumeration Date | 01/27/2012 |
| Last Update Date | 11/21/2023 |
| Certification Date | 08/03/2022 |
| Medicare PECOS PAC ID | 2668635822 |
|---|---|
| Medicare Enrollment ID | O20120525000270 |
News Archive
West Nile virus is killing millions more birds and affecting many more bird species than previously thought, according to new research from a multi-university team of researchers.
Threshold Pharmaceuticals, Inc. today announced that it has initiated a multi-center, randomized, controlled, crossover Phase 2 clinical trial of TH-302 in combination with gemcitabine in patients with first line pancreatic cancer. TH-302 is a proprietary tumor selective Hypoxia-Activated Prodrug that specifically targets tumor hypoxia.
Today President Barack Obama signed into law The Patient Protection and Affordable Care Act (H.R.3590). As an association representing behavioral healthcare professionals and organizations, we are committed to improving the lives of people of all ages experiencing psychiatric and substance use disorders. This historic legislation offers hope and help in a number of ways.
Researchers in Argentina have conducted a pre-clinical study demonstrating the safety and pharmacokinetic performance of a new nasal spray formulation designed to suppress the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134491855 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | 1174 (Louisiana) | Primary |
| Provider Name | Adam Brown Hess |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1609153303 PECOS PAC ID: 3577726736 Enrollment ID: I20210916001544 |
News Archive
West Nile virus is killing millions more birds and affecting many more bird species than previously thought, according to new research from a multi-university team of researchers.
Threshold Pharmaceuticals, Inc. today announced that it has initiated a multi-center, randomized, controlled, crossover Phase 2 clinical trial of TH-302 in combination with gemcitabine in patients with first line pancreatic cancer. TH-302 is a proprietary tumor selective Hypoxia-Activated Prodrug that specifically targets tumor hypoxia.
Today President Barack Obama signed into law The Patient Protection and Affordable Care Act (H.R.3590). As an association representing behavioral healthcare professionals and organizations, we are committed to improving the lives of people of all ages experiencing psychiatric and substance use disorders. This historic legislation offers hope and help in a number of ways.
Researchers in Argentina have conducted a pre-clinical study demonstrating the safety and pharmacokinetic performance of a new nasal spray formulation designed to suppress the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 3 days ago
| Provider Name | Candice Gaspard |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1316511918 PECOS PAC ID: 0244688000 Enrollment ID: I20231205000816 |
News Archive
West Nile virus is killing millions more birds and affecting many more bird species than previously thought, according to new research from a multi-university team of researchers.
Threshold Pharmaceuticals, Inc. today announced that it has initiated a multi-center, randomized, controlled, crossover Phase 2 clinical trial of TH-302 in combination with gemcitabine in patients with first line pancreatic cancer. TH-302 is a proprietary tumor selective Hypoxia-Activated Prodrug that specifically targets tumor hypoxia.
Today President Barack Obama signed into law The Patient Protection and Affordable Care Act (H.R.3590). As an association representing behavioral healthcare professionals and organizations, we are committed to improving the lives of people of all ages experiencing psychiatric and substance use disorders. This historic legislation offers hope and help in a number of ways.
Researchers in Argentina have conducted a pre-clinical study demonstrating the safety and pharmacokinetic performance of a new nasal spray formulation designed to suppress the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 3 days ago
| Provider Name | Leigh Ann Hess |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1376041079 PECOS PAC ID: 9830548288 Enrollment ID: I20231211000680 |
News Archive
West Nile virus is killing millions more birds and affecting many more bird species than previously thought, according to new research from a multi-university team of researchers.
Threshold Pharmaceuticals, Inc. today announced that it has initiated a multi-center, randomized, controlled, crossover Phase 2 clinical trial of TH-302 in combination with gemcitabine in patients with first line pancreatic cancer. TH-302 is a proprietary tumor selective Hypoxia-Activated Prodrug that specifically targets tumor hypoxia.
Today President Barack Obama signed into law The Patient Protection and Affordable Care Act (H.R.3590). As an association representing behavioral healthcare professionals and organizations, we are committed to improving the lives of people of all ages experiencing psychiatric and substance use disorders. This historic legislation offers hope and help in a number of ways.
Researchers in Argentina have conducted a pre-clinical study demonstrating the safety and pharmacokinetic performance of a new nasal spray formulation designed to suppress the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 3 days ago
News Archive
West Nile virus is killing millions more birds and affecting many more bird species than previously thought, according to new research from a multi-university team of researchers.
Threshold Pharmaceuticals, Inc. today announced that it has initiated a multi-center, randomized, controlled, crossover Phase 2 clinical trial of TH-302 in combination with gemcitabine in patients with first line pancreatic cancer. TH-302 is a proprietary tumor selective Hypoxia-Activated Prodrug that specifically targets tumor hypoxia.
Today President Barack Obama signed into law The Patient Protection and Affordable Care Act (H.R.3590). As an association representing behavioral healthcare professionals and organizations, we are committed to improving the lives of people of all ages experiencing psychiatric and substance use disorders. This historic legislation offers hope and help in a number of ways.
Researchers in Argentina have conducted a pre-clinical study demonstrating the safety and pharmacokinetic performance of a new nasal spray formulation designed to suppress the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 3 days ago
Bayou Rapides Rehab, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3620 Bayou Rapides Rd, Alexandria, LA 71303 Phone: 318-561-2010 Fax: 318-561-0098 | |
Family Counseling Agency, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1404 Murray St, Alexandria, LA 71301 Phone: 318-448-0284 Fax: 318-448-0280 | |
Merakey Pennsylvania Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 233 Pecan Park Ave, Suite A And B, Alexandria, LA 71303 Phone: 215-836-3131 Fax: 215-273-5975 | |
Caring Choices Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 5411 Coliseum Blvd, Alexandria, LA 71303 Phone: 318-484-6850 Fax: 318-484-6844 | |
Freedom Therapy Center, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1102 Texas Ave, Alexandria, LA 71301 Phone: 318-613-0147 | |
Louisiana Counseling Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5920 Coliseum Blvd, Alexandria, LA 71303 Phone: 318-332-5090 Fax: 318-443-9116 | |
Christus St. Frances Cabrini Palliative Care Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3330 Masonic Dr, Suite 105, Alexandria, LA 71301 Phone: 318-449-2480 Fax: 318-448-6555 |